Talazoparib,Enzalutamide
Pfizer,Astellas
['pcsm', 'enzalutamide', 'talazo', 'enzalu', 'crpc']
adding talazoparib to first-line treatment with enzalutamide improves rpfs in patients with hrr-deficient mcrpc, a phase 3 trial presented at asco 2023 suggests. #asco23 #pcsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.